Pharmacokinetics of antiparasitic drugs is the discipline that helps to improve the success of antiparasitic drug development by designing and performing various in vivo and in vitro pharmacokinetic studies based on drug development needs. It mainly refers to the use of mathematical processing to quantitatively describe the dynamics of antiparasitic drugs or other exogenous substances in the human body, and thus to study the toxicological and pharmacological implications of the absorption, distribution, metabolism, and excretion (ADME) of drugs in humans. The basis for determining the dose and interval of drug administration is the ability of the drug to reach a safe and effective concentration at its site of action. The concentration of the drug at the site of action is dynamically influenced by the in vivo processes of the drug. Currently, pharmacokinetics has penetrated into many disciplines such as pharmacotherapeutics, biopharmacology, and toxicology, and is used throughout the development of drugs, becoming an important hallmark of today's in-depth drug research. In the development of innovative antiparasitic drugs, pharmacokinetic studies are as important as pharmacodynamic and toxicological studies and have become an important part of preclinical and clinical studies of antiparasitic drugs.

Ace Infectious' pharmacokinetic laboratory is GLP certified by NMPA, and experimental studies follow the guidelines of ICH, NMPA, and FDA. We can design and conduct in vivo and in vitro pharmacokinetic tests according to clients' needs, and provide a complete set of pharmacokinetic evaluation and optimization services for our clients. We are recognized by our international clients for our high-quality data to meet the needs of different stages of new drug development.

Learn more: antiparasitic drug protein binding rate